Skip to content
Maui Sky – Lifestyle
Author:
Equillium, Inc.
Equillium to Participate in Upcoming Investor Conferences
November 5, 2026
Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504
October 26, 2026
Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
October 6, 2026
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
October 5, 2026
Equillium Announces Poster Presentations at the 7th International AHR Conference
September 29, 2026
Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum
September 16, 2026
Equillium to Participate in Upcoming Investor Conferences
September 2, 2026
Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 13, 2026
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 2, 2026
Equillium to Participate in the 2026 Jefferies Global Healthcare Conference
May 28, 2026
1
2
Next Page
→